[HKEX] THE GEM LISTING COMMITTEE CRITICISES MR. GUO XIA WILLIAM, EXECUTIVE DIRECTOR AND CHAIRMAN OF CHINA HEALTH GROUP INC. (STOCK CODE: 8225), FOR BREACHING THE GEM LISTING RULES AND THE DIRECTOR’S UNDERTAKING

This decision emphasises the importance of compliance with securities dealing restrictions within the GEM Listing Rules.

Directors are restricted from dealing in securities during Blackout Periods to remove or mitigate any suspicion of abuse by directors of listed issuers.  Directors’ strict compliance is of fundamental importance to the integrity and confidence in the governance of listed issuers and the securities market in Hong Kong.   

The GEM Listing Committee of The Stock Exchange of Hong Kong Limited (“Committee”)

Read More: https://www.hkex.com.hk/News/News-Release/2019/191202news?sc_lang=en